Guizhou Xinbang Pharmaceutical Co Ltd (002390) — Net Asset Momentum
Guizhou Xinbang Pharmaceutical Co Ltd (002390) recorded a net asset momentum of -1.7% as of December 2024, with net assets of CN¥7.02 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is Guizhou Xinbang Pharmaceutical Co Ltd's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Guizhou Xinbang Pharmaceutical Co Ltd Net Asset Momentum (2006–2024)
This chart tracks Guizhou Xinbang Pharmaceutical Co Ltd's year-over-year net asset growth across 19 annual reporting periods from 2006 to 2024. The most recent momentum reading is -1.7%, with net assets of CN¥7.02 Billion CNY as of December 2024. Check Guizhou Xinbang Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Net Asset History for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)
The table below shows the complete annual net asset history for Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 002390 company net worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥7.02 Billion | CN¥9.03 Billion | CN¥2.01 Billion | ▼ -1.7% |
| 2023 | CN¥7.14 Billion | CN¥9.24 Billion | CN¥2.10 Billion | ▲ +1.1% |
| 2022 | CN¥7.07 Billion | CN¥9.79 Billion | CN¥2.73 Billion | ▲ +3.5% |
| 2021 | CN¥6.83 Billion | CN¥9.63 Billion | CN¥2.80 Billion | ▲ +32.1% |
| 2020 | CN¥5.17 Billion | CN¥9.66 Billion | CN¥4.49 Billion | ▲ +2.4% |
| 2019 | CN¥5.05 Billion | CN¥10.42 Billion | CN¥5.37 Billion | ▼ -2.3% |
| 2018 | CN¥5.17 Billion | CN¥10.85 Billion | CN¥5.69 Billion | ▼ -23.5% |
| 2017 | CN¥6.76 Billion | CN¥11.95 Billion | CN¥5.20 Billion | ▲ +4.2% |
| 2016 | CN¥6.49 Billion | CN¥10.80 Billion | CN¥4.31 Billion | ▲ +143.0% |
| 2015 | CN¥2.67 Billion | CN¥6.50 Billion | CN¥3.84 Billion | ▲ +8.6% |
| 2014 | CN¥2.46 Billion | CN¥5.22 Billion | CN¥2.77 Billion | ▲ +137.3% |
| 2013 | CN¥1.04 Billion | CN¥1.49 Billion | CN¥450.69 Million | ▲ +1.3% |
| 2012 | CN¥1.02 Billion | CN¥1.33 Billion | CN¥311.99 Million | ▲ +4.4% |
| 2011 | CN¥979.53 Million | CN¥1.24 Billion | CN¥264.02 Million | ▲ +2.1% |
| 2010 | CN¥959.70 Million | CN¥1.13 Billion | CN¥165.81 Million | ▲ +279.6% |
| 2009 | CN¥252.83 Million | CN¥470.35 Million | CN¥217.51 Million | ▲ +21.7% |
| 2008 | CN¥207.69 Million | CN¥442.73 Million | CN¥235.04 Million | ▲ +19.3% |
| 2007 | CN¥174.08 Million | CN¥391.07 Million | CN¥216.99 Million | ▲ +20.7% |
| 2006 | CN¥144.17 Million | CN¥379.34 Million | CN¥235.18 Million | — |